These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20144539)

  • 21. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of community-based nurses in harm reduction for HIV prevention: a South East and South Asia case study.
    Limbu B
    Int J Drug Policy; 2008 Jun; 19(3):211-3. PubMed ID: 18440796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.
    Mathers BM; Degenhardt L; Phillips B; Wiessing L; Hickman M; Strathdee SA; Wodak A; Panda S; Tyndall M; Toufik A; Mattick RP;
    Lancet; 2008 Nov; 372(9651):1733-45. PubMed ID: 18817968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing harm reduction for heroin users in Afghanistan, the worldwide opium supplier.
    Maguet O; Majeed M
    Int J Drug Policy; 2010 Mar; 21(2):119-21. PubMed ID: 20171864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries--the current and future state of the art.
    Hammett TM; Parsons DS
    Int J Drug Policy; 2014 May; 25(3):336-9. PubMed ID: 24559603
    [No Abstract]   [Full Text] [Related]  

  • 27. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.
    Bull Narc; 1993; 45(1):19-46. PubMed ID: 8305904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management of HIV-hepatitis C virus coinfection in injection drug users.
    Khalsa JH; Kresina T; Sherman K; Vocci F
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S1-6. PubMed ID: 16265605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advocacy for harm reduction in China: a new era dawns.
    Reid G; Aitken C
    Int J Drug Policy; 2009 Jul; 20(4):365-70. PubMed ID: 19097773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global HIV cohort studies among injecting drug users and future vaccine trials.
    Woratanarat T
    J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
    Foss AM; Watts CH; Vickerman P; Azim T; Guinness L; Ahmed M; Rodericks A; Jana S
    Addiction; 2007 Jan; 102(1):114-25. PubMed ID: 17207129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Russia: sex, drugs, AIDS and the Doctors Without Borders].
    Veeken H
    Ned Tijdschr Geneeskd; 1998 May; 142(20):1158-61. PubMed ID: 9623240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexisting or conjoined: the growth of the international drug users' movement through participation with International Harm Reduction Association Conferences.
    Byrne J; Albert ER
    Int J Drug Policy; 2010 Mar; 21(2):110-1. PubMed ID: 19942422
    [No Abstract]   [Full Text] [Related]  

  • 40. Global estimates of prevalence of HCV infection among injecting drug users.
    Aceijas C; Rhodes T
    Int J Drug Policy; 2007 Oct; 18(5):352-8. PubMed ID: 17854722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.